R-Pharm International, LLC
R-Pharm International, LLC
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) | Skin and Connective Tissue Diseases, connective tissue disorder, muscle tissue disorder, musculoskeletal system disorder, polymyalgia rheumatica, rheumatic disorder | Active, not recruiting | Phase 3 | 2026-06-30 | NCT07670546 | |
| Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, juvenile idiopathic arthritis, musculoskeletal system disorder, rheumatic disorder, systemic-onset juvenile idiopathic arthritis | Not yet recruiting | Phase 3 | 2026-06-04 | NCT07625384 | |
| A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | Active, not recruiting | Phase 2 | 2026-04-28 | NCT07553988 | |
| Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, juvenile idiopathic arthritis, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 2 | 2026-04-08 | NCT07517575 | |
| Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, familial Mediterranean fever, hereditary disease, hereditary periodic fever syndrome | Recruiting | Phase 2 | 2024-12-16 | NCT05190991 | |
| Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, familial Mediterranean fever, hereditary disease, hereditary periodic fever syndrome | Active, not recruiting | Phase 2 | 2024-12-06 | NCT05092776 | |
| Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases | interstitial lung disease, lung disorder, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2024-11-19 | NCT06440746 | |
| Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis | cardiovascular disorder, heart disorder, idiopathic recurrent pericarditis, pericarditis | Active, not recruiting | Phase 3 | 2024-11-15 | NCT05673902 |